CLCR Call: May 17, 2021

For Public Health

At a glance

The May 17, 2021, Clinical Laboratory COVID-19 Response (CLCR) call included updates on antigen testing, biosafety, SARS-CoV-2 variants, and laboratory supplies, as well as updates from FDA.

Format: MP3
Language: English (US)
Size: 22 MB

Agenda

Archived LOCS Materials Access

Contact LOCS to access archived LOCS materials.

Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)

Antigen Testing Guidance: Muktha Natrajan, CDC Division of Laboratory Systems (DLS)

Biosafety Guidance Update: Aufra C. Araujo, CDC Division of Laboratory Systems (DLS)

SARS-CoV-2 Variants Update: Steve Oberste, CDC Laboratory and Testing Task Force for the COVID-19 Response

How the Federal Government is Addressing Laboratory Supply Issues: Steven Santos, HHS Testing and Diagnostics Workgroup, and Matthew Hubbard, HHS Testing and Diagnostics Workgroup

FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)

Meeting materials

Content Source
About this page
Published: November 20, 2024
Updated: May 17, 2021

This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.

Reviewed: May 17, 2021

The information on this page was last reviewed by subject matter experts to ensure accuracy.